The role of chemotherapy in the carcinomas and sarcomas that involve the ba
se of skull is reviewed in this article. An established role exists for cis
platin-based multimodality treatment in the definitive management of nasoph
aryngeal carcinoma. Extrapolation from data generated for other head and ne
ck squamous cell cancers also suggests a role for concomitant chemotherapy
and radiation when these tumors involve the skull base. For the other neopl
asms in this region, including the nonsquamous cell cancers of salivary gla
nd and paranasal sinus, and the sarcomas and metastatic tumors, chemotherap
y remains a palliative tool with limited overall benefit.